Burger Wessel A C, Mobbs Jesse I, Rana Bhavika, Wang Jinan, Joshi Keya, Gentry Patrick R, Yeasmin Mahmuda, Venugopal Hariprasad, Bender Aaron M, Lindsley Craig W, Miao Yinglong, Christopoulos Arthur, Valant Celine, Thal David M
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia.
Australian Research Council Centre for Cryo-Electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia.
Nat Commun. 2025 Jul 31;16(1):7046. doi: 10.1038/s41467-025-62212-z.
The M muscarinic acetylcholine receptor (M mAChR) represents a promising therapeutic target for neurological disorders. However, the high conservation of its orthosteric binding site poses significant challenges for drug development. While selective positive allosteric modulators (PAMs) offer a potential solution, a structural understanding of the M mAChR and its allosteric binding sites remains limited. Here, we present a 2.8 Å cryo-electron microscopy structure of the M mAChR complexed with heterotrimeric G protein and the agonist iperoxo, completing the active-state structural characterization of the mAChR family. To identify the binding site of M-selective PAMs, we implement an integrated approach combining mutagenesis, pharmacological assays, structural biology, and molecular dynamics simulations. Our mutagenesis studies reveal that selective M PAMs bind outside previously characterized M mAChR allosteric sites. Subsequently, we obtain a 2.1 Å structure of M mAChR co-bound with acetylcholine and the selective PAM VU6007678, revealing an allosteric pocket at the extrahelical interface between transmembrane domains 3 and 4 that is confirmed through mutagenesis and simulations. These findings demonstrate the diverse mechanisms of allosteric regulation in mAChRs and highlight the value of integrating pharmacological and structural approaches to identify allosteric binding sites.
M型毒蕈碱型乙酰胆碱受体(M mAChR)是神经系统疾病一个很有前景的治疗靶点。然而,其正构结合位点的高度保守性给药物开发带来了重大挑战。虽然选择性正变构调节剂(PAMs)提供了一种潜在的解决方案,但对M mAChR及其变构结合位点的结构理解仍然有限。在此,我们展示了与异源三聚体G蛋白和激动剂iperoxo复合的M mAChR的2.8埃冷冻电子显微镜结构,完成了mAChR家族的活性状态结构表征。为了确定M选择性PAMs的结合位点,我们采用了一种综合方法,结合诱变、药理学测定、结构生物学和分子动力学模拟。我们的诱变研究表明,选择性M PAMs结合在先前表征的M mAChR变构位点之外。随后,我们获得了与乙酰胆碱和选择性PAM VU6007678共同结合的M mAChR的2.1埃结构,揭示了跨膜结构域3和4之间螺旋外界面处的一个变构口袋,这通过诱变和模拟得到了证实。这些发现证明了mAChRs变构调节的多种机制,并突出了整合药理学和结构方法来识别变构结合位点的价值。